Evidence map›Paper›PMID 39256067›Full record

ArticleMedical dosimetry : official journal of the American Association of Medical Dosimetrists

A lung SBRT treatment planning technique to focus high dose on gross disease.

Kirk Luca, Aparna H Kesarwala, Kathryn Benner, Sibo Tian, Matthew Thomas, Eduard Schreibmann, Justin Roper

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical dosimetry : official journal of the American Association of Medical Dosimetrists. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kirk LucaDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: kirk.luca@emoryhealthcare.org.
Aparna H KesarwalaDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Kathryn BennerDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Sibo TianDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Matthew ThomasDepartment of Radiation Oncology, Roper St. Francis Healthcare, Charleston, SC, USA.
Eduard SchreibmannDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Justin RoperDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.

Funding

Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung CancerR21EB033994 · NIBIB · EMORY UNIVERSITY · PI KESARWALA, APARNA · 2023 to 2025
$822k
NIBIB NIH HHS R21 EB033994
6 · The paper itself

Abstract

This study investigated a straightforward treatment planning technique for definitive stereotactic body radiation therapy (SBRT) for patients with early-stage lung cancer aimed at increasing dose to gross disease by strategically penalizing the normal tissue objective (NTO) in the Eclipse

Indexed as

Lung NeoplasmsRadiosurgeryRadiotherapy Planning, Computer-AssistedHumansRadiotherapy DosageBiologic equivalent doseConformityFall-offLungNormal tissue objectiveStereotactic body radiation therapy

Identifiers

PMID39256067
PMCPMC11788066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.